Ankyrin Repeat Domain 11 (ANKRD11) Peptide
ANKRD11
Reactivity: Human
Host: Synthetic
BP, IHC, WB
-
- Target See all ANKRD11 products
- ANKRD11 (Ankyrin Repeat Domain 11 (ANKRD11))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ANKRD11 antibody (Catalog #: ARP33542_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ANKRD11 (Ankyrin Repeat Domain 11 (ANKRD11))
- Background
-
ANKRD11 is a member of a novel family of ankyrin repeats containing cofactors (ANCOs) that interact with p160 coactivators to inhibit ligand-dependent transactivation. ANKRD11 encodes a large nuclear protein with five ankyrin repeats, and parts of its sequences have been reported as nasopharyngeal carcinoma susceptibility protein and medulloblastoma antigen. This gene also colocalizes and interacts with histone deacetylases.
Alias Symbols: T13, LZ16, ANCO1, ANCO-1
Protein Interaction Partner: HDAC3,NCOA1,NCOA2,NCOA3,HDAC3,HDAC4,HDAC5,NCOA2,SRC,ANKRD11,HDAC3,NCOA2,NCOA3
Protein Size: 2663 - Molecular Weight
- 298 kDa
- Gene ID
- 29123
- NCBI Accession
- NM_013275, NP_037407
- UniProt
- Q9UHR3
-
You are here:
